Biomedical hormonization is often surrounded by misconceptions that reduce it to controversy or fear, obscuring its scientific foundations. In reality, hormonization is a well-established medical practice, grounded in endocrinology and supported by decades of clinical research and therapeutic use.
Across medicine, hormonal interventions are routinely applied to treat endocrine disorders, manage chronic conditions, and support physiological balance. Within this broader context, biomedical hormonization should be understood not as an exception, but as part of standard medical care aimed at improving health outcomes and quality of life.
One persistent myth portrays hormonization as inherently dangerous or experimental. While hormonal therapies do carry risks, these are neither unique nor unmanaged. Through evidence-based protocols, continuous monitoring, and individualized dosing, modern medicine minimizes adverse effects while maximizing benefits—just as it does with any long-term treatment.
Moving beyond the myth requires a shift from ideology to science. Biomedical hormonization is not defined by speculation or stigma, but by data, ethics, and patient-centered care. When evaluated objectively, it stands as a legitimate and vital tool in contemporary medicine, reflecting both scientific progress and respect for human well-being.
